Exodus Point Capital Management, LP Biocryst Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$4.89 - $7.65 $2.82 Million - $4.41 Million	-577,092 Reduced 76.94%	172,961 $879,000
Q3 2023 Nov 09, 2023	SELL	$6.71 - $7.92 $3.1 Million - $3.66 Million	-462,494 Reduced 38.14%	750,053 $5.31 Million
Q2 2023 Aug 10, 2023	SELL	$6.96 - $8.81 $63,572 - $80,470	-9,134 Reduced 0.75%	1,212,547 $8.54 Million
Q1 2023 May 11, 2023	BUY	$7.94 - $11.84 $9.53 Million - $14.2 Million	1,199,839 Added 5493.27%	1,221,681 $10.2 Million
Q4 2022 Feb 13, 2023	SELL	$10.5 - $14.2 $7.22 Million - $9.76 Million	-687,443 Reduced 96.92%	21,842 $251,000
Q3 2022 Nov 10, 2022	BUY	$10.79 - $14.81 $3,949 - $5,420	366 Added 0.05%	709,285 $8.94 Million
Q2 2022 Aug 19, 2022	BUY	$7.89 - $17.88 $5.59 Million - $12.7 Million	708,919 New	708,919 $7.5 Million
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $1.4 Million - $2.39 Million	-120,827 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $877,987 - $1.21 Million	78,532 Added 185.68%	120,827 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $1.13 Million - $1.4 Million	-79,308 Reduced 65.22%	42,295 $608,000
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $1.16 Million - $2.1 Million	121,603 New	121,603 $1.92 Million
Q3 2020 Nov 16, 2020	SELL	$3.43 - $5.53 $123,373 - $198,908	-35,969 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $68,341 - $201,786	35,969 New	35,969 $171,000

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.